Absolutely. It's not only from a cost perspective, reducing costs. You're not reinventing the wheel. You're not trying to create another study that will come to the same result. Certainly, I would caution that any studies done elsewhere still need to go through that peer review aspect to verify the validity of the study done. Certainly, it would not only expedite access to products, but also cut the cost down tremendously.
On October 29th, 2024. See this statement in context.